AAAAAA
Results:
1-14
|
Results: 14
Authors:
Langer, O
Dolle, F
Valette, H
Halldin, C
Vaufrey, F
Fuseau, C
Coulon, C
Ottaviani, M
Nagren, K
Bottlaender, M
Maziere, B
Crouzel, C
Citation: O. Langer et al., Synthesis of high-specific-radioactivity 4- and 6-[F-18]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart, BIO MED CH, 9(3), 2001, pp. 677-694
Authors:
Poyot, T
Conde, F
Gregoire, MC
Frouin, V
Coulon, C
Fuseau, C
Hinnen, F
Dolle, F
Hantraye, P
Bottlaender, M
Citation: T. Poyot et al., Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa, J CEREBR B, 21(7), 2001, pp. 782-792
Authors:
Valette, H
Dolle, F
Guenther, I
Hinnen, F
Fuseau, C
Coulon, C
Peglion, JL
Crouzel, C
Citation: H. Valette et al., Myocardial kinetics of the C-11-labeled enantiomers of the Ca2+ channel inhibitor S11568: An in vivo study, J NUCL MED, 42(6), 2001, pp. 932-937
Authors:
Langer, O
Valette, H
Dolle, F
Halldin, C
Loc'h, C
Fuseau, C
Coulon, C
Ottaviani, M
Bottlaender, M
Maziere, B
Crouzel, C
Citation: O. Langer et al., High specific radioactivity (1R,2S)-4-[F-18]fluorometaraminol: A PET radiotracer for mapping sympathetic nerves of the heart, NUCL MED BI, 27(3), 2000, pp. 233-238
Authors:
Ponchant, M
Galea, H
Bottlaender, M
Coulon, C
Fuseau, C
Ottaviani, M
Crouzel, C
Citation: M. Ponchant et al., [Tetrazoyl-C-11]LY202157 synthesis for in vivo studies of the NMDA receptor channel complex, J LABEL C R, 43(13), 2000, pp. 1311-1320
Authors:
Dolle, F
Bottlaender, M
Demphel, S
Emond, P
Fuseau, C
Coulon, C
Ottaviani, M
Valette, H
Loc'h, C
Halldin, C
Mauclaire, L
Guilloteau, D
Maziere, B
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET, J LABEL C R, 43(10), 2000, pp. 997-1004
Authors:
Lundkvist, C
Loc'h, C
Halldin, C
Bottlaender, M
Ottaviani, M
Coulon, C
Fuseau, C
Mathis, C
Farde, L
Maziere, B
Citation: C. Lundkvist et al., Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter, NUCL MED BI, 26(5), 1999, pp. 501-507
Authors:
Valette, H
Dolle, F
Guenther, I
Demphel, S
Rasetti, C
Hinnen, F
Fuseau, C
Crouzel, C
Citation: H. Valette et al., Preliminary evaluation of 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta 1-adrenoceptor ligand for PET, NUCL MED BI, 26(1), 1999, pp. 105-109
Authors:
Dolci, L
Dolle, F
Valette, H
Vaufrey, F
Fuseau, C
Bottlaender, M
Crouzel, C
Citation: L. Dolci et al., Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging, BIO MED CH, 7(3), 1999, pp. 467-479
Authors:
Delforge, J
Bottlaender, M
Loc'h, C
Guenther, I
Fuseau, C
Bendriem, B
Syrota, A
Maziere, B
Citation: J. Delforge et al., Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach, J CEREBR B, 19(5), 1999, pp. 533-546
Authors:
Valette, H
Bottlaender, M
Dolle, F
Guenther, I
Fuseau, C
Coulon, C
Ottaviani, M
Crouzel, C
Citation: H. Valette et al., Imaging central nicotinic acetylcholine receptors in baboons with [F-18]fluoro-A-85380, J NUCL MED, 40(8), 1999, pp. 1374-1380
Authors:
Helfenbein, J
Loc'h, C
Bottlaender, M
Emond, P
Coulon, C
Ottaviani, M
Fuseau, C
Chalon, S
Guenther, I
Besnard, JC
Frangin, Y
Guilloteau, D
Maziere, B
Citation: J. Helfenbein et al., A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments, LIFE SCI, 65(25), 1999, pp. 2715-2726
Authors:
Dolle, F
Dolci, L
Valette, H
Hinnen, F
Vaufrey, F
Guenther, I
Fuseau, C
Coulon, C
Bottlaender, M
Crouzel, C
Citation: F. Dolle et al., Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors, J MED CHEM, 42(12), 1999, pp. 2251-2259
Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo
Authors:
Valette, H
Bottlaender, M
Dolle, F
Guenther, I
Coulon, C
Hinnen, F
Fuseau, C
Ottaviani, M
Crouzel, C
Citation: H. Valette et al., Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo, LIFE SCI, 64(5), 1998, pp. PL93-PL97
Risultati:
1-14
|